In vitro inhibition of gastric acid secretion by vasopressin
- 1 July 1987
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 139 (3) , 281-286
- https://doi.org/10.1016/0014-2999(87)90585-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Centrally administered PGE2 inhibits gastric secretion in the rat by releasing vasopressinEuropean Journal of Pharmacology, 1984
- Studies on the mechanism of inhibition of hepatic cAMP accumulation by vasopressinFEBS Letters, 1983
- The rat isolated stomach sheet; an in vitro model for the study of the physiology and pharmacology of gastric acid secretionJournal of Pharmacological Methods, 1982
- Vasopressin: An essential pressor factor for blood pressure recovery following hemorrhagePeptides, 1982
- [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressinJournal of Medicinal Chemistry, 1980
- A rat isolated gastric mucosal preparation for studying the pharmacology of gastric secretion and the synthesis or release of endogenous substancesJournal of Pharmacological Methods, 1978
- Acid secretion by guinea‐pig isolated stomach.The Journal of Physiology, 1976
- Gastric secretion in relation to mucosal blood flow studied by a clearance technic.Journal of Clinical Investigation, 1966